Hypertension in Diabetes Mellitus: Role of β-Blockers

Messerli, Franz H.; Grossman, Ehud
July 2001
Drugs;Jul2001, Vol. 61 Issue 10
Academic Journal
Comments on the efficacy of several antihypertensive drugs. Reduction in cardiovascular events and cardiovascular mortality; Interrelation between beta blockers and metabolic disturbance; Complications in hypertension in relation to coronary morbidity and mortality.


Related Articles

  • Betting on Beta-Blockers. Wetherbee, Kris // Town & Country;Dec2001, Vol. 155 Issue 5259, p160 

    Details the role of beta-blockers in preventing hypertension.

  • BETA BLOCKERS WITH CLONIDINE? Rashid, Harooner; Cohn, Peter F. // Cortlandt Forum;9/25/2003, Vol. 16 Issue 9, p50 

    Discusses the common errors in hypertension control. Use of a beta blocker/clonidine combination in treating hypertension; Increase in blood pressure due to increased alpha tone; Danger of rebound hypertension.

  • Drugs for high blood pressure--is new necessarily better? E.B. // Medical Update;Oct95, Vol. 19 Issue 4, p4 

    Discusses the advantages of diuretics and beta blockers over calcium channel blockers and angiotensin-converting enzyme (ACE) inhibitors in treating hypertension. Effectivity of diuretics in treating persons with isolated systolic hypertension; Recommendation from the Joint National Committee...

  • New approaches to the uses of beta blocking drugs in hypertension. Prichard, B N C; Graham, B R; Cruickshank, J M // Journal of Human Hypertension;Apr2000 Supplement, Vol. 14 Issue 4, pS63 

    After a slow start, beta-blockers have become widely used as first-line agents in the treatment of hypertension, and recommended as such in recently published guidelines. There is evidence that the beta[SUB1]-selective agents are more efficacious than non-selective blockers that inhibit both...

  • β-Adrenergic Blockers in Systemic Hypertension: Pharmacokinetic Considerations Related to the Current Guidelines. Frishman, W.H.; Alwarshetty, M. // Clinical Pharmacokinetics;May2002, Vol. 41 Issue 7, p505 

    β-Adrenergic blockade has provided one of the major pharmacotherapeutic advances of the 20th century. β-Blockers are first-line drugs for the management of systemic hypertension, used alone and in combination with other antihypertensive agents. Drugs in the β-blocking class have the...

  • Post-Transplant HT Controlled by Quinapril and Atenolol.  // Kidney;Sep/Oct99, Vol. 8 Issue 5, p218 

    Discusses an abstract of the article, entitled 'ACE inhibitor versus beta-blocker for the treatment of hypertension in renal allograft recipients,' by M. Hausberg, M. Barenbrock, H. Hohage and others.

  • Are Off-Label Drugs Ever OK? Amanda, First // Runner's World;Feb2013, Vol. 48 Issue 2, p018 

    The article presents information related to the use of beta-blockers for the treatment of high blood pressure.

  • New propranolol controls A.M. blood pressure spikes. Karpa, Kelly Dowhower // Drug Topics;4/7/2003, Vol. 147 Issue 7, p14 

    Focuses on Innopran XL, a propranolol product from Reliant Pharmaceuticals and Eurand. Designation as the only beta-blocker indicated for evening administration; Control of blood pressure increase; Significance of bedtime dosing; Chronotherapeutic approach used by the drug's extended-release...

  • Hypertension in Diabetes Mellitus: Role of β-Blockers. Martin, Una; Dunne, Fidelma; Kendall, Martin // Drugs;Jul2001, Vol. 61 Issue 10 

    Examines the role of beta blockers on the treatment of hypertension in diabetes mellitus in Great Britain. Rate of heart attack in patients treated with beta blockers; Incidence of coronary artery disease in patients with hypertension and diabetes mellitus; Effects of antihypertensive therapy...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics